Research
Faster entry into first-in-human trials shortens the path for new therapies, including the longevity drugs this corpus tracks.
US Food and Drug Administration·2026-10-16
Research
Sponsored access lowers the cost barrier for university biology groups to try a domain-specific frontier model.
OpenAI·2026-10-15
Market & Business
A major device maker taking a route to own a surgical-robot platform raises the competitive stakes in robotic surgery, especially in the US.
The Robot Report·2026-10-15
Market & Business
A dedicated AI office at the largest US biomedical funder is likely to become the place that sets AI policy for NIH-funded research.
Federal Register (National Institutes of Health)·2026-10-14
Research
Genomic foundation models are being pitched for variant interpretation; this is independent evidence that zero-shot outputs can be wrong in direction, not just in size, so validate before relying on them.
bioRxiv·2026-10-07
Research
Most clinical prediction models work in hours or days, while bedside decisions are made in minutes. This is a step toward models that can inform those decisions, pending peer review and prospective testing.
medRxiv·2026-10-06
Research
If drugmakers start citing aging-clock results, biological age becomes a marketed endpoint, and how much the clocks disagree with each other becomes a practical question.
MIT Technology Review·2026-10-06
Research
Provenance for designed biological molecules is a biosecurity lever that regulators and labs are likely to start asking about.
Google DeepMind·2026-09-30
Research
This is an AI scientific harness with results checked in the wet lab, a step beyond benchmark-only claims.
Microsoft Research·2026-09-29
Market & Business
A personal-use robotic medical device has cleared US regulators, a precedent for other assistive robots seeking approval.
New Atlas·2026-09-27
Research
A precomputed variant-effect map makes genome-wide predictions easy to query; treat them as hypotheses until a disease-specific check like the ALS study backs them.
Google DeepMind·2026-09-08
Market & Business
Credit decides patents, publications and funding, so the attribution convention set now will price the next decade of AI-assisted discovery.
MIT Technology Review·2026-08-21
Research
Wearables produce far more signal than anyone can chase, so the useful product is the shortlist rather than the stream.
Google Research·2026-08-21
Market & Business
Regulatory clearance is what decides whether an imaging model reaches a real clinic, and Centiloid output is what makes one hospital’s number comparable to another’s.
Imaging Technology News·2026-08-18
Market & Business✓ verified
The interesting claim is not the robot, it is the flywheel: an operator with a fleet in the field compounds its own deployment data into the next version — the moat any services business should be asking whether it is building.
Diligent Robotics·2026-08-17
Research
Results still come from simulated consultations with actors, not patients — but the modality has moved from typed history to live video, which is where most real triage actually happens.
Google Research·2026-08-11
Frontier Models
Anyone who abandoned ordinary health, clinical or biology-teaching work in a Claude product because it kept refusing has a concrete reason to retry it — and a named list of topics that still will not go through.
Anthropic·2026-08-07
Market & Business
Bottom-up clinician pull — not executive mandate — is emerging as the deciding factor in which clinical-AI deployments actually scale.
Abridge·2026-08-04
Market & Business
A clean example of the assistive framing that clears regulators: the robot narrows the error band, the clinician keeps the hands.
The Robot Report·2026-07-28
Open Source & Self-Hostable
Surgical-robot policy work has been gated on scarce hardware time; a faster-than-real-time simulator with published weights moves that loop onto one workstation GPU.
NVIDIA / Hugging Face·2026-07-27
Research
A concrete answer to "what are open vision models actually for" — general-purpose perception, on-device, inside somebody’s daily mobility.
Meta AI·2026-07-27
Market & Business✓ verified
Operating-room floor space is the constraint that keeps surgical robots out of smaller hospitals, so a table-integrated architecture is an access argument as much as an engineering one — and de novo means a regulator agreed it is a new class.
The Robot Report·2026-07-25
Market & Business✓ verified
A live template — and test case — for shipping AI products on top of regulated personal data at consumer scale.
OpenAI·2026-07-23
Research✓ verified
Brain-computer interfaces have mostly lived in research demos and rehab clinics; a sub-200ms decode loop that plugs into off-the-shelf robots is what turns "thought control" from a lab trick into a control scheme other robotics teams can actually build on.
The Robot Report·2026-07-20